Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Immunology|February 1, 1987
Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine proteaseM H Nissen, O J Bjerrum, T Plesner, et al.
European Journal of Biochemistry|April 30, 1990
Limited proteolysis of beta 2-microglobulin at Lys-58 by complement component C1sM H Nissen, P Roepstorff, L Thim, et al.
The Journal of Biological Chemistry|June 22, 2001
Conformational intermediate of the amyloidogenic protein beta 2-microglobulin at neutral pHN H Heegaard, J W Sen, N C Kaarsholm, et al.
Scandinavian Journal of Immunology|December 11, 2002
IL-15 induces unspecific effector functions in human peptide-specific CD8+ T-cell culturesS T Lyngstrand, P A Würtzen, N Ødum, et al.
Scandinavian Journal of Immunology|December 1, 1996
MHC class I phenotype and function of human beta 2-microglobulin transgenic murine lymphocytesL Bjerager, L O Pedersen, S Bregenholt, et al.
Cancer Letters|June 22, 1999
Human p53(264-272) HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic miceT R Petersen, S Bregenholta, L O Pedersen, et al.
Scandinavian Journal of Immunology|January 25, 2003
Self-peptides with intermediate capacity to bind and stabilize MHC class I molecules may be immunogenicM L M Andersen, M Ruhwald, M H Nissen, et al.
Scandinavian Journal of Immunology|December 12, 2007
Cellular expression or binding of desLys58-beta2 microglobulin is not dependent on the presence of the tri-molecular MHC class I complexM Wang, D B Corlin, N H H Heegaard, et al.
Pageof 6